DEF 14A

Company

Traws Pharma, Inc.

Filed

October 11, 2024

Period of Report

October 31, 2024

Accession Number

0001104659-24-107822

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →